We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Role of Oral Glutathione in Skin Whitening

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01016080
First Posted: November 18, 2009
Last Update Posted: November 18, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Chulalongkorn University
November 17, 2009
November 18, 2009
November 18, 2009
February 2009
May 2009   (Final data collection date for primary outcome measure)
Skin melanin index [ Time Frame: 4 weeks ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Role of Oral Glutathione in Skin Whitening
Glutathione as an Oral Whitening Agent: a Randomized, Double-blind, Placebo-controlled Study
Oral and intravenous glutathione have been used widely to whiten the skin. The investigators tested this hypothesis by giving oral glutathione for 4 weeks to medical students.
Not Provided
Interventional
Phase 1
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Skin Whitening
  • Drug: glutathione
    250 mg capsules, twice daily, orally
  • Drug: placebo
    250 mg capsules, twice daily, orally
  • Active Comparator: oral glutathione
    glutathione, 500 mg, taken orally twice daily
    Intervention: Drug: glutathione
  • Placebo Comparator: placebo capsules
    identical-appearing placebo capsules
    Intervention: Drug: placebo
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
60
June 2009
May 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Healthy medical students

Exclusion Criteria:

  • history of skin cancer, especially melanoma
  • consumption of any preparations containing glutathione within 1 month of enrollment
  • pigmentary disorders or any dermatoses
Sexes Eligible for Study: All
18 Years to 25 Years   (Adult)
Not Provided
Contact information is only displayed when the study is recruiting subjects
Thailand
 
 
NCT01016080
COA840/2008
No
Not Provided
Not Provided
Pravit Asawanonda, Chulalongkorn University
Chulalongkorn University
Not Provided
Not Provided
Chulalongkorn University
November 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP